Drug susceptibility testing using molecular techniques can enhance tuberculosis diagnosis | Zendy

Thomas C. Victor | Zendy; Rabia Johnson | Zendy; A. Jordaan | Zendy; Robin M. Warren | Zendy; Marleine Bosman | Zendy; Douglas B. Young | Zendy; Judit N. Nagy | Zendy; John Wain | Zendy; Paul D. van Helden | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug susceptibility testing using molecular techniques can enhance tuberculosis diagnosis

Author(s) -

Thomas C. Victor,

Rabia Johnson,

A. Jordaan,

Robin M. Warren,

Marleine Bosman,

Douglas B. Young,

Judit N. Nagy,

John Wain,

Paul D. van Helden

Publication year - 2008

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.320

Subject(s) - genotype , isoniazid , tuberculosis , rifampicin , sputum , reproducibility , medicine , biology , pathology , genetics , chemistry , chromatography , gene

Sputum samples were collected from tuberculosis patients in a high tuberculosis incidence area in the Western Cape, South Africa. The aim of this study was to evaluate the performance and time to diagnosis of a genotypic drug susceptibility testing method.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research